Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial | JOURNAL OF CLINICAL ONCOLOGY |